论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
晚发性抑郁症免疫特征的生物信息学筛选和实验验证
Authors Wang X, Gao Y, Wang D, Du X, Liu S
Received 8 August 2024
Accepted for publication 21 November 2024
Published 28 November 2024 Volume 2024:20 Pages 2347—2361
DOI https://doi.org/10.2147/NDT.S490717
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Taro Kishi
Xinxia Wang,1,2,* Yao Gao,1,2,* Dan Wang,3 Xinzhe Du,1,2 Sha Liu1,2
1Department of Psychiatry, First Hospital/First Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China; 2Shanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China; 3Shanxi Provincial Integrated TCM and WM Hospital, Taiyuan, Shanxi, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Sha Liu, Department of Psychiatry, First Hospital/First Clinical Medical College of Shanxi Medical University, Taiyuan, SX030001, People’s Republic of China, Tel +8615803400167, Email liusha1984114@163.com
Background: Late-onset depression (LOD) is often associated with more severe cognitive impairment and a higher risk of disability and suicide. Emerging evidence suggests that immune system problems may be involved. This study aims to systematically characterize the genetic signature of LOD based on the immune landscape.
Methods: The expression profile of GSE76826 was obtained from the Gene Expression Omnibus (GEO) database to gather gene expression data for 10 LOD patients and 12 healthy controls (HC). Various analyses, such as Single-Sample Gene Set Enrichment Analysis (ssGSEA) and Weighted Gene Co-expression Network Analysis (WGCNA), were used to mine key genes closely related to LOD. ImmuCellAI helped us understand differences in the immune environment between LOD patients and controls, and we used an LOD animal model to validate the relevant immune characteristics.
Results: We found enriched immune pathways linked to LOD and adaptive immune responses. Using advanced bioinformatics techniques, we identified two key genes: apelin (APLN) and leptin (LEP), which have good diagnostic efficacy (AUC=0.925, 95% CI=1.00– 0.83) for LOD. Neutrophil infiltration increased significantly in LOD, while CD8+ T lymphocytes (CD8_T) decreased. We finally constructed an animal model of LOD, validated two key genes and microglia marker genes in blood and hippocampus, and detected elevated pro-inflammatory factors such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α).
Conclusion: We identified and validated the presence of aberrant expression of APLN and LEP in LOD and described a possible immune mechanism involving increased release of IL-6 and TNF-α, leading to decreased CD8_T infiltration and increased neutrophil infiltration. Meanwhile, peripheral inflammation across the blood-brain barrier further promotes microglia activation, leading to neuronal damage.
Keywords: late-onset depression, ssGSEA, immune cell infiltration, APLN, LEP, microglia